Table 4
Benefit of SK in patients with a window period ≤6 h
Antibody levels
Benefit with SK
No
Yes
≤320
0 (0%)
55 (73.33%)
320+
19 (100%)
20 (26.67%)
Total
19
75
p<0.001.
SK, streptokinase.